Nrf2 in TIME: The Emerging Role of Nuclear Factor Erythroid 2-Related Factor 2 in the Tumor Immune Microenvironment
Molecules and Cells · 2023-03 · 46 (3) · 142-152
DOI: 10.14348/molcells.2023.2183 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules and Cells, 2023-03. Verfasst von Jialin Feng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, UK. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Cytokines. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 3.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Nuclear factor erythroid 2-related factor 2 (Nrf2) mediates the cellular antioxidant response, allowing adaptation and survival under conditions of oxidative, electrophilic and inflammatory stress, and has a role in metabolism, inflammation and immunity. Activation of Nrf2 provides broad and long-lasting cytoprotection, and is often hijacked by cancer cells, allowing their survival under unfavorable conditions. Moreover, Nrf2 activation in established human tumors is associated with resistance to chemo-, radio-, and immunotherapies. In addition to cancer cells, Nrf2 activation can also occur in tumor-associated macrophages (TAMs) and facilitate an anti-inflammatory, immunosuppressive tumor immune microenvironment (TIME). Several cancer cell-derived metabolites, such as itaconate, L-kynurenine, lactic acid and hyaluronic acid, play an important role in modulating the TIME and tumor-TAMs crosstalk, and have been shown to activate Nrf2. The effects of Nrf2 in TIME are context-depended, and involve multiple mechanisms, including suppression of pro-inflammatory cytokines, increased expression of programmed cell death ligand 1 (PD-L1), macrophage colony-stimulating factor (M-CSF) and kynureninase, accelerated catabolism of cytotoxic labile heme, and facilitating the metabolic adaptation of TAMs. This understanding presents both challenges and opportunities for strategic targeting of Nrf2 in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
- Department of Pharmacology and Molecular Sciences and Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
ORCID-Profile: Jialin Feng, Oliver J Read, Albena T Dinkova-Kostova
Förderung
- Medical Research Council
Zitieren
APA
Feng, J., Read, O. J., & Dinkova-Kostova, A. T. (2023). Nrf2 in TIME: The Emerging Role of Nuclear Factor Erythroid 2-Related Factor 2 in the Tumor Immune Microenvironment. Molecules and Cells, 46(3), 142-152. https://doi.org/10.14348/molcells.2023.2183
Vancouver
Feng J, Read OJ, Dinkova-Kostova AT. Nrf2 in TIME: The Emerging Role of Nuclear Factor Erythroid 2-Related Factor 2 in the Tumor Immune Microenvironment. Molecules and Cells. 2023;46(3):142-152. doi:10.14348/molcells.2023.2183
BibTeX
@article{Feng2023,
author = {Feng, Jialin and Read, Oliver J and Dinkova-Kostova, Albena T},
title = {Nrf2 in TIME: The Emerging Role of Nuclear Factor Erythroid 2-Related Factor 2 in the Tumor Immune Microenvironment},
journal = {Molecules and Cells},
year = {2023},
volume = {46},
number = {3},
pages = {142--152},
doi = {10.14348/molcells.2023.2183}
}
EUVIMED